Core Laboratories Inc. (CLB)
NYSE: CLB · Real-Time Price · USD
10.30
+0.38 (3.83%)
Oct 5, 2026, 11:08 AM EDT - Market open
Core Laboratories Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 473 | 746 | 813 | 825 | 940 | 1,033 | |
Market Cap Growth | -19.88% | -8.16% | -1.51% | -12.21% | -8.98% | -12.45% |
Enterprise Value | 615 | 894 | 992 | 1,042 | 1,167 | 1,277 |
Last Close Price | 9.92 | 15.99 | 17.22 | 17.53 | 20.08 | 22.06 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 19.86 | 25.16 | 25.88 | 22.50 | 48.32 | 52.35 |
Forward PE | 16.16 | 21.66 | 18.55 | 17.98 | 23.39 | 24.73 |
PS Ratio | 0.88 | 1.42 | 1.55 | 1.62 | 1.92 | 2.20 |
PB Ratio | 1.67 | 2.74 | 3.22 | 3.59 | 4.97 | 6.41 |
P/TBV Ratio | 2.84 | 4.88 | 5.78 | 6.97 | 12.16 | 21.13 |
P/FCF Ratio | 41.83 | 33.26 | 18.74 | 58.07 | 63.77 | 44.82 |
P/OCF Ratio | 16.13 | 20.16 | 14.41 | 33.29 | 37.66 | 28.23 |
PEG Ratio | - | 14.84 | 0.99 | 0.36 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.15 | 1.70 | 1.89 | 2.04 | 2.38 | 2.72 |
EV/EBITDA Ratio | 10.46 | 13.47 | 14.79 | 14.32 | 19.38 | 21.36 |
EV/EBIT Ratio | 14.13 | 17.28 | 19.04 | 18.29 | 27.11 | 30.93 |
EV/FCF Ratio | 54.92 | 39.83 | 22.88 | 73.32 | 79.18 | 55.45 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.59 | 0.60 | 0.71 | 0.94 | 1.18 | 1.59 |
Debt / EBITDA Ratio | 2.12 | 1.89 | 2.06 | 2.30 | 2.78 | 3.18 |
Debt / FCF Ratio | 15.18 | 7.31 | 4.16 | 15.16 | 15.09 | 11.10 |
Net Debt / Equity Ratio | 0.51 | 0.52 | 0.64 | 0.87 | 1.10 | 1.48 |
Net Debt / EBITDA Ratio | 2.49 | 2.13 | 2.40 | 2.75 | 3.44 | 3.98 |
Net Debt / FCF Ratio | 13.09 | 6.30 | 3.71 | 14.09 | 14.04 | 10.33 |
Asset Turnover | 0.87 | 0.90 | 0.89 | 0.88 | 0.85 | 0.82 |
Inventory Turnover | 7.10 | 7.33 | 6.42 | 6.05 | 7.44 | 8.80 |
Quick Ratio | 1.37 | 1.35 | 1.38 | 1.57 | 1.27 | 1.37 |
Current Ratio | 2.12 | 2.03 | 2.16 | 2.53 | 2.05 | 2.08 |
Return on Equity (ROE) | 9.05% | 11.59% | 13.34% | 17.68% | 11.24% | 17.09% |
Return on Assets (ROA) | 4.45% | 5.53% | 5.56% | 6.11% | 4.64% | 4.49% |
Return on Invested Capital (ROIC) | 6.74% | 8.28% | 8.60% | 12.39% | 7.11% | 5.85% |
Return on Capital Employed (ROCE) | 8.70% | 10.80% | 10.80% | 11.40% | 9.10% | 8.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.35% | 3.98% | 3.86% | 4.45% | 2.07% | 1.91% |
FCF Yield | 2.39% | 3.01% | 5.33% | 1.72% | 1.57% | 2.23% |
Dividend Yield | 0.39% | 0.25% | 0.23% | 0.23% | 0.20% | 0.18% |
Payout Ratio | 7.68% | 6.30% | 5.97% | 5.09% | 9.53% | 9.30% |
Buyback Yield / Dilution | 1.80% | 1.38% | -0.34% | -1.52% | -0.26% | -4.98% |
Total Shareholder Return | 2.21% | 1.63% | -0.11% | -1.29% | -0.06% | -4.79% |